Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
17-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #1461
advertisement
Clinical Ophthalmology
46
Showing records 1 to 25 |
Display all abstracts in
Clinical Ophthalmology
66654
Measurement of central corneal thickness by ultrasonic pachymeter and oculus pentacam in patients with well-controlled glaucoma: hospital-based comparative study
Rashid RF
Clinical Ophthalmology
2016; 10: 359-364
67518
Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study
Tellez-Vazquez J
Clinical Ophthalmology
2016; 10: 617-626
66767
Comparison between the EX-PRESS P-50 implant and trabeculectomy in patients with open-angle glaucoma
Mendoza-Mendieta ME
Clinical Ophthalmology
2016; 10: 269-276
67145
Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs
Lo JS
Clinical Ophthalmology
2016; 10: 583-586
67443
Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Perera SA
Clinical Ophthalmology
2016; 10: 757-764
67517
A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Stevens A
Clinical Ophthalmology
2016; 10: 635-641
67174
Corneal biomechanics in asymmetrical normal-tension glaucoma
Helmy H
Clinical Ophthalmology
2016; 10: 503-510
66695
Review of external ocular compression: clinical applications of the ocular pressure estimator
Korenfeld MS
Clinical Ophthalmology
2016; 10: 343-357
67184
Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials
Uusitalo H
Clinical Ophthalmology
2016; 10: 445-454
67146
Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery
Chaku M
Clinical Ophthalmology
2016; 10: 547-553
66720
Teleophthalmology: improving patient outcomes?
Sreelatha OK
Clinical Ophthalmology
2016; 10: 285-295
67185
Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon
Shen J
Clinical Ophthalmology
2016; 10: 373-383
67463
In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Urbaneja D
Clinical Ophthalmology
2016; 10: 665-669
67146
Risk factors for tube exposure as a late complication of glaucoma drainage implant surgery
Netland PA
Clinical Ophthalmology
2016; 10: 547-553
67443
Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
Ting DS
Clinical Ophthalmology
2016; 10: 757-764
67174
Corneal biomechanics in asymmetrical normal-tension glaucoma
Leila M
Clinical Ophthalmology
2016; 10: 503-510
66720
Teleophthalmology: improving patient outcomes?
Ramesh SV
Clinical Ophthalmology
2016; 10: 285-295
66654
Measurement of central corneal thickness by ultrasonic pachymeter and oculus pentacam in patients with well-controlled glaucoma: hospital-based comparative study
Farhood QK
Clinical Ophthalmology
2016; 10: 359-364
67463
In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery
Morilla-Grasa A
Clinical Ophthalmology
2016; 10: 665-669
66767
Comparison between the EX-PRESS P-50 implant and trabeculectomy in patients with open-angle glaucoma
López-Venegas AP
Clinical Ophthalmology
2016; 10: 269-276
67184
Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials
Egorov E
Clinical Ophthalmology
2016; 10: 445-454
67185
Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon
Bejanian M
Clinical Ophthalmology
2016; 10: 373-383
67517
A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Iliev ME
Clinical Ophthalmology
2016; 10: 635-641
66695
Review of external ocular compression: clinical applications of the ocular pressure estimator
Dueker DK
Clinical Ophthalmology
2016; 10: 343-357
67145
Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs
Pang PM
Clinical Ophthalmology
2016; 10: 583-586
«
1
2
»
Issue
17-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement